High Cost Drugs – Wales
NHS Structural Policy — Health Bill
Abolishing NHS England. The Health Bill was introduced to the House of Commons on 14 May 2026. It proposes to abolish NHS England and transfer the bulk of its functions to the Secretary of State for Health and Social Care and to Integrated Care Boards.3 ICBs will become strategic commissioners of almost all services, including […]
Health Bill — Committee Stage Under Way
The Health Bill passed its second reading in the House of Commons on 1 June 2026. The Public Bill Committee held its first oral evidence sessions on 16 June 2026 and began line-by-line scrutiny the same day, with the Committee expected to report by 5pm on 16 July 2026. The Bill remains controversial: the Health […]
NATIONAL ROLLOUT COMPLETE — NHS Wales
AWTTC completed Phase II national rollout across all seven NHS Wales Health Boards in April 2025.
- Collect AWMSG and NICE criteria evidence directly from clinicians across all 7 Health Boards
- Using Auto-Approval, ensure Clinicians receive approval to treat immediately — average 5–10 minutes
- Keep a complete audit trail: cross-border Wales/England treatments fully tracked
- Validate/Challenge provider invoices including cross-border providers
Introduction
Paperless Solution Across All Wales
Getting rid of paper forms to collect evidence of AWMSG and NICE criteria being followed not only streamlines the process for the commissioner, it also gives the clinician a transparent view of the process on their screens. The AWTTC completed Phase II national rollout across all seven NHS Wales Health Boards in April 2025, with forms importable from the England system.
Request History & Document Storage
The Blueteq HCD system provides a complete patient history, storing and displaying all information and documentation in one place in a paperless environment. No filing is required and all vital data is immediately to hand. Cross-border patients treated in England under Welsh commissioning are fully tracked within the same system.
Customised Reporting for NHS Wales
A full range of reports are available on demand to help prioritise work-loads, ensure that all requests are processed in a timely manner and within the target timescales and all follow up actions are captured.
Without Blueteq
Cross-border patient governance — Wales commissioners paying for England-delivered treatments without visibility.
AWMSG compliance assumed, not evidenced at the point of prescribing.
Invoice mismatches from cross-border providers identified weeks or months later.
No consolidated view of HCD activity across all seven Health Boards.
For Commissioners / Stakeholders
- Save on invoice values through discrepancy detection
- Reduce unnecessary spending via eligibility gate-keeping
- Maximise budget impact on patient care
- Match invoices to requests in minutes
- Combined clinical + financial data in one secure system
- Advanced reporting drives quality improvements
For Commissioners / Stakeholders
- Save on invoice values through discrepancy detection
- Reduce unnecessary spending via eligibility gate-keeping
- Maximise budget impact on patient care
- Match invoices to requests in minutes
- Combined clinical + financial data in one secure system
- Advanced reporting drives quality improvements
WHY CHOOSE US
Unique Benefits Summary: High Cost Drugs - Wales
- AWMSG and NICE criteria both supported — a single platform for all Welsh approvals
- 200+ forms imported from NHS England — no form-building required from scratch
- Cross-border tracking — Wales/England patient treatments fully governed in one system
- Invoice matching recovers value through discrepancy identification
- Patient History displays all information and documentation in one place
- No software to install and maintain locally — web-based, simple subscription
- UK-Based. Employee-Owned. Independently Governed.
